HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Fight Adulteration With Supplier Qualification Guide, Supplement Industry Says

This article was originally published in The Tan Sheet

Executive Summary

The Council for Responsible Nutrition calls on FDA to work with industry on a tool that will help thwart economically motivated adulteration - ingredient supplier qualification guidelines

You may also be interested in...



Qualifying Suppliers For US Supplement Ingredient Identity Requirement Still An Option With Thorns

Failing to qualify suppliers “one of the more common citations” FDA inspectors find at supplement facilities, says ORA deputy director Michael Dutcher. “If you're not sort of reconfirming once in a while it could lead to a problem with your products that you weren't even expecting.”

SIDI Group Expects "Passport" To Business With Standardized CofA

The Standardized Information on Dietary Supplement Ingredients Working Group's certificate of analysis guidance specifies general information to include, along with the results of analytical testing on an ingredient lot or batch and other information, such as country of origin, if applicable.

SIDI Group Expects "Passport" To Business Growth With Standardized CofA

Dietary supplement ingredient suppliers should approach standardizing information in their certificates of analysis as an investment that will pay off in business growth, say industry stakeholders who wrote a CofA guideline

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS136653

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel